G. Koumakis

发表

What’s in a name: Framing treated wastewater as recycled water increases willingness to use and willingness to pay

R. Mellon, K. Tsagarakis, A. Menegaki, 2009 .

European Lung Cancer Working Party Clinical Practice Guidelines. Non-Small Cell Lung Cancer: III. Metastatic disease

J. Lafitte, P. Houtte, M. Paesmans, 2006 .

A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

P. van Houtte, M. Paesmans, T. Berghmans, 2009, Lung cancer.

A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.

J. Lafitte, P. van Houtte, M. Paesmans, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

European Lung Cancer Working Party Clinical Practice Guidelines Non-small Cell Lung Cancer: II. Unresectable Non-metastatic Stages

J. Lafitte, V. Ninane, C. Mascaux, 2006 .

A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.

J. Lafitte, V. Ninane, P. van Houtte, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

J. Lafitte, V. Ninane, M. Paesmans, 2001, British Journal of Cancer.

Chemotherapy improves low performance status lung cancer patients

J. Lafitte, V. Ninane, M. Paesmans, 2007, European Respiratory Journal.

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

J. Lafitte, V. Ninane, M. Paesmans, 2000, British Journal of Cancer.

A case of paraneoplastic autoimmune pancreatitis: mini-review of paraneoplastic syndromes in breast cancer.

L. Lekakis, G. Koumakis, D. Tryfonopoulos, 2012, Anticancer research.

Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in patients with lymphoma, myeloma and solid tumors

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1996, European journal of haematology.

Relation between hematological recovery and number of transplanted mononuclear cells in patients after high dose chemotherapy with peripheral blood stem cell rescue.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1995, Blood cells, molecules & diseases.

A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation

G. Koumakis, A. Efremidis, V. Barbounis, 1995, Supportive Care in Cancer.

Optimal Timing (Preemptive versus Supportive) of Granulocyte Colony-Stimulating Factor Administration following High-Dose Cyclophosphamide

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1999, Oncology.

Salvage chemotherapy with cisplatin and 5-fluorouracil in metastatic breast cancer. Particular activity against liver metastases.

L. Lekakis, G. Koumakis, D. Tryfonopoulos, 2012, Anticancer research.

Control of irinotecan-induced diarrhea by octreotide after loperamide failure

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 2001, Supportive Care in Cancer.

The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1999, Supportive Care in Cancer.

Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1996, Bone marrow transplantation.

Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial.

G. Koumakis, A. Efremidis, V. Barbounis, 2002, Lung cancer.

Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 2005, Anticancer research.

Proliferating fibroblasts and HeLa cells co-cultured in vitro reciprocally influence growth patterns, protein expression, chromatin features and cell survival.

J. G. Delinasios, E. Vairaktaris, G. Tsangaris, 2015, Anticancer research.

Role of Stromal Fibroblasts in Cancer: Promoting or Impeding?

Shant Kumar, G. Koumakis, F. Angeli, 2009, Tumor Biology.

Aromatase Inhibitor-Associated Tendinopathy and Muscle Tendon Rupture: Report of Three Cases of This Exceedingly Rare Adverse Event

G. Koumakis, D. Tryfonopoulos, A. Grivas, 2018, Case Reports in Oncology.

Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1995, Bone marrow transplantation.

Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin

M. Tolia, G. Koumakis, N. Tsoukalas, 2013, Oncology letters.

A phase II study of flutamide in ovarian cancer.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 1997, Oncology.

Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

The antiemetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation

G. Koumakis, M. Vassilomanolakis, A. Efremidis, 2022 .

A three-arm phase III randomised trial testing accelerated chemotherapy with GM-CSF or cotrimoxazole in extensive disease smal-cell lung cancer

J. Lafitte, M. Paesmans, J. Sculier, 2001 .

European Lung Cancer Working Party Clinical Practice Guidelines. Non-small cell lung cancer: I. Early stages

J. Lafitte, V. Ninane, T. Berghmans, 2006 .

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.

J. Lafitte, V. Ninane, M. Paesmans, 1999, European journal of cancer.

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.

Y. Wang, A. Schneeweiss, Ming Yan, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.

T. Berghmans, J. Sculier, G. Koumakis, 2004, Lung cancer.

Short communication Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial

G. Koumakis, A. Efremidis, V. Barbounis, 2002 .

First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer.

G. Koumakis, G. Koumakis, N. Apostolikas, 2005, Breast.